ReadYourDNA

Liraglutide (Victoza)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Liraglutide

What it is

Liraglutide is a GLP-1 receptor agonist: it mimics the gut hormone GLP-1, which makes the pancreas release insulin when blood sugar is high, slows stomach emptying and reduces appetite. Injected once a day, it is used for type 2 diabetes (Victoza), where it also lowers the chance of heart attack and stroke, and for weight management (Saxenda).

How genes come into it

As a peptide, liraglutide is broken down by enzymes throughout the body, not by liver CYP enzymes. Studies have looked mainly at GLP1R, the gene for the receptor it acts on, linking some variants to how much blood sugar or weight fell, and at CNR1 and TCF7L2. The findings come from a few studies, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Liraglutide. Upload your DNA file to see which of these rows apply to you.

Rated evidence (2 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

GLP1R rs10305420: Level 3. Efficacy: Obesity, Polycystic Ovary Syndrome. 1.

GLP1R rs6923761: Level 3. Efficacy: Obesity, Polycystic Ovary Syndrome. 1.

Response (7 findings)

Studies of how well it worked in people carrying a variant.

CNR1 rs1049353: Genotypes CT + TT is associated with increased clinical benefit to liraglutide in people with Diabetes Mellitus, Type 2 and Obesity as compared to genotype CC.

GLP1R rs10305420: Genotype TT is associated with increased clinical benefit to liraglutide in people with Diabetes Mellitus, Type 2 as compared to genotypes CC + CT.

GLP1R rs10305420: Genotypes CT + TT are associated with decreased response to liraglutide in women with Obesity and Polycystic Ovary Syndrome as compared to genotype CC.

GLP1R rs3765467: Genotype GG is associated with increased clinical benefit to exenatide or liraglutide in people with Diabetes Mellitus, Type 2 as compared to genotypes AA + AG.

Other findings (2 findings)

Studies that do not fall into the groups above.

GLP1R rs6923761: Genotypes AA + AG is associated with increased response to exenatide or liraglutide in people with Obesity as compared to genotype GG.

TCF7L2 rs7903146: Genotypes CT + TT is not associated with increased response to exenatide or liraglutide in people with Obesity as compared to genotype CC.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Byetta (GLP-1 Agonists)

GLP-1 Agonists (class) (GLP-1 Agonists)

Ozempic (GLP-1 Agonists)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com